Ladenburg Thalmann Financial Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
$88K Sell
25,673
-500
-2% -$1.71K ﹤0.01% 3119
2019
Q3
$75K Buy
26,173
+25,550
+4,101% +$73.2K ﹤0.01% 3142
2019
Q2
$3K Buy
623
+134
+27% +$645 ﹤0.01% 4850
2019
Q1
$4K Buy
489
+100
+26% +$818 ﹤0.01% 4720
2018
Q4
$3K Sell
389
-100
-20% -$771 ﹤0.01% 4738
2018
Q3
$4K Buy
489
+100
+26% +$818 ﹤0.01% 4658
2018
Q2
$2K Hold
389
﹤0.01% 4838
2018
Q1
$2K Hold
389
﹤0.01% 4838
2017
Q4
$2K Hold
389
﹤0.01% 4750
2017
Q3
$2K Hold
389
﹤0.01% 4644
2017
Q2
$2K Hold
389
﹤0.01% 4569
2017
Q1
$3K Hold
389
﹤0.01% 4452
2016
Q4
$2K Hold
389
﹤0.01% 4509
2016
Q3
$2K Sell
389
-20,000
-98% -$103K ﹤0.01% 4448
2016
Q2
$58K Buy
20,389
+10,000
+96% +$28.4K ﹤0.01% 2563
2016
Q1
$29K Buy
10,389
+10,000
+2,571% +$27.9K ﹤0.01% 2983
2015
Q4
$4K Hold
389
﹤0.01% 4109
2015
Q3
$4K Sell
389
-7,000
-95% -$72K ﹤0.01% 4013
2015
Q2
$110K Buy
7,389
+3,500
+90% +$52.1K ﹤0.01% 2032
2015
Q1
$35K Buy
3,889
+389
+11% +$3.5K ﹤0.01% 2814
2014
Q4
$43K Buy
3,500
+500
+17% +$6.14K ﹤0.01% 2459
2014
Q3
$29K Hold
3,000
﹤0.01% 2367
2014
Q2
$38K Buy
+3,000
New +$38K ﹤0.01% 2212
2014
Q1
Sell
-1,000
Closed -$8K 3752
2013
Q4
$8K Hold
1,000
﹤0.01% 3038
2013
Q3
$7K Sell
1,000
-27,000
-96% -$189K ﹤0.01% 3017
2013
Q2
$43K Buy
+28,000
New +$43K ﹤0.01% 1823